Jacqueline Ramírez et al.
Drug metabolism and disposition: the biological fate of chemicals, 43(7), 928-935 (2015-04-15)
OTS167 is a potent maternal embryonic leucine zipper kinase inhibitor undergoing clinical testing as antineoplastic agent. We aimed to identify the UDP-glucuronosyltransferases (UGTs) involved in OTS167 metabolism, study the relationship between UGT genetic polymorphisms and hepatic OTS167 glucuronidation, and investigate